News
CASBF
5.40
NaN%
--
Weekly Report: what happened at CASBF last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at CASBF last week (1117-1121)?
Weekly Report · 11/24 09:06
Weekly Report: what happened at CASBF last week (1110-1114)?
Weekly Report · 11/17 09:06
Weekly Report: what happened at CASBF last week (1103-1107)?
Weekly Report · 11/10 09:06
Weekly Report: what happened at CASBF last week (1027-1031)?
Weekly Report · 11/03 09:06
Weekly Report: what happened at CASBF last week (1020-1024)?
Weekly Report · 10/27 09:06
Weekly Report: what happened at CASBF last week (1013-1017)?
Weekly Report · 10/20 09:06
Weekly Report: what happened at CASBF last week (1006-1010)?
Weekly Report · 10/13 09:06
Weekly Report: what happened at CASBF last week (0929-1003)?
Weekly Report · 10/06 09:06
Weekly Report: what happened at CASBF last week (0922-0926)?
Weekly Report · 09/29 09:06
Weekly Report: what happened at CASBF last week (0915-0919)?
Weekly Report · 09/22 09:06
Weekly Report: what happened at CASBF last week (0908-0912)?
Weekly Report · 09/15 11:58
Weekly Report: what happened at CASBF last week (0901-0905)?
Weekly Report · 09/08 12:00
Weekly Report: what happened at CASBF last week (0825-0829)?
Weekly Report · 09/01 11:54
Weekly Report: what happened at CASBF last week (0818-0822)?
Weekly Report · 08/25 12:08
Weekly Report: what happened at CASBF last week (0811-0815)?
Weekly Report · 08/18 11:57
Weekly Report: what happened at CASBF last week (0804-0808)?
Weekly Report · 08/11 12:07
Weekly Report: what happened at CASBF last week (0728-0801)?
Weekly Report · 08/04 12:10
Weekly Report: what happened at CASBF last week (0721-0725)?
Weekly Report · 07/28 12:11
Weekly Report: what happened at CASBF last week (0714-0718)?
Weekly Report · 07/21 11:58
More
Webull provides a variety of real-time CASBF stock news. You can receive the latest news about Cansino Biologic through multiple platforms. This information may help you make smarter investment decisions.
About CASBF
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.